Balaji K Tamarappoo1, Yuka Otaki1, Tali Sharir2,3, Lien-Hsin Hu1,4, Heidi Gransar1, Andrew J Einstein5, Mathews B Fish6, Terrence D Ruddy7, Philipp Kaufmann8, Albert J Sinusas9, Edward J Miller9, Timothy M Bateman10, Sharmila Dorbala11, Marcelo Di Carli11, Evann Eisenberg1, Joanna X Liang1, Damini Dey1, Daniel S Berman1, Piotr J Slomka1. 1. Department of Medicine (Division of Artificial Intelligence), Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles (B.K.T., Y.O., L.-H.H., H.G., E.E., J.X.L., D.D., D.S.B., P.J.S.). 2. Department of Nuclear Cardiology, Assuta Medical Centers, Tel Aviv, Israel (T.S.). 3. Ben Gurion University of the Negev, Beer Sheba, Israel (T.S.). 4. Department of Nuclear Medicine, Taipei Veterans General Hospital, Taiwan (L.-H.H.). 5. Division of Cardiology, Department of Medicine, and Department of Radiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital (A.J.E.). 6. Oregon Heart and Vascular Institute, Sacred Heart Medical Center, Springfield, OR (M.B.F.). 7. Division of Cardiology, University of Ottawa Heart Institute, ON, Canada (T.D.R.). 8. Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Switzerland (P.K.). 9. Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (A.J.S., E.J.M.). 10. Cardiovascular Imaging Technologies LLC, Kansas City, MO (T.M.B.). 11. Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, MA (S.D., M.D.C.).
Abstract
BACKGROUND: Semiquantitative assessment of stress myocardial perfusion defect has been shown to have greater prognostic value for prediction of major adverse cardiac events (MACE) in women compared with men in single-center studies with conventional single-photon emission computed tomography (SPECT) cameras. We evaluated sex-specific difference in the prognostic value of automated quantification of ischemic total perfusion defect (ITPD) and the interaction between sex and ITPD using high-efficiency SPECT cameras with solid-state detectors in an international multicenter imaging registry (REFINE SPECT [Registry of Fast Myocardial Perfusion Imaging With Next-Generation SPECT]). METHODS: Rest and exercise or pharmacological stress SPECT myocardial perfusion imaging were performed in 17 833 patients from 5 centers. MACE was defined as the first occurrence of death or myocardial infarction. Total perfusion defect (TPD) at rest, stress, and ejection fraction were quantified automatically by software. ITPD was given by stressTPD-restTPD. Cox proportional hazards model was used to evaluate the association between ITPD versus MACE-free survival and expressed as a hazard ratio. RESULTS: In 10614 men and 7219 women, with a median follow-up of 4.75 years (interquartile range, 3.7-6.1), there were 1709 MACE. In a multivariable Cox model, after adjusting for revascularization and other confounding variables, ITPD was associated with MACE (hazard ratio, 1.08 [95% CI, 1.05-1.1]; P<0.001). There was an interaction between ITPD and sex (P<0.001); predicted survival for ITPD<5% was worse among men compared to women, whereas survival among women was worse than men for ITPD≥5%, P<0.001. CONCLUSIONS: In the international, multicenter REFINE SPECT registry, moderate and severe ischemia as quantified by ITPD from high-efficiency SPECT is associated with a worse prognosis in women compared with men.
BACKGROUND: Semiquantitative assessment of stress myocardial perfusion defect has been shown to have greater prognostic value for prediction of major adverse cardiac events (MACE) in women compared with men in single-center studies with conventional single-photon emission computed tomography (SPECT) cameras. We evaluated sex-specific difference in the prognostic value of automated quantification of ischemic total perfusion defect (ITPD) and the interaction between sex and ITPD using high-efficiency SPECT cameras with solid-state detectors in an international multicenter imaging registry (REFINE SPECT [Registry of Fast Myocardial Perfusion Imaging With Next-Generation SPECT]). METHODS: Rest and exercise or pharmacological stress SPECT myocardial perfusion imaging were performed in 17 833 patients from 5 centers. MACE was defined as the first occurrence of death or myocardial infarction. Total perfusion defect (TPD) at rest, stress, and ejection fraction were quantified automatically by software. ITPD was given by stressTPD-restTPD. Cox proportional hazards model was used to evaluate the association between ITPD versus MACE-free survival and expressed as a hazard ratio. RESULTS: In 10614 men and 7219 women, with a median follow-up of 4.75 years (interquartile range, 3.7-6.1), there were 1709 MACE. In a multivariable Cox model, after adjusting for revascularization and other confounding variables, ITPD was associated with MACE (hazard ratio, 1.08 [95% CI, 1.05-1.1]; P<0.001). There was an interaction between ITPD and sex (P<0.001); predicted survival for ITPD<5% was worse among men compared to women, whereas survival among women was worse than men for ITPD≥5%, P<0.001. CONCLUSIONS: In the international, multicenter REFINE SPECT registry, moderate and severe ischemia as quantified by ITPD from high-efficiency SPECT is associated with a worse prognosis in women compared with men.
Authors: Ernest V Garcia; Tracy L Faber; C David Cooke; Russell D Folks; Ji Chen; Cesar Santana Journal: J Nucl Cardiol Date: 2007-07 Impact factor: 5.952
Authors: Louise D Metz; Mary Beattie; Robert Hom; Rita F Redberg; Deborah Grady; Kirsten E Fleischmann Journal: J Am Coll Cardiol Date: 2006-12-29 Impact factor: 24.094
Authors: Sanjiv S Gambhir; Daniel S Berman; Jack Ziffer; Michael Nagler; Martin Sandler; Jim Patton; Brian Hutton; Tali Sharir; Shlomo Ben Haim; Simona Ben Haim Journal: J Nucl Med Date: 2009-04 Impact factor: 10.057
Authors: Sharmila Dorbala; Karthik Ananthasubramaniam; Ian S Armstrong; Panithaya Chareonthaitawee; E Gordon DePuey; Andrew J Einstein; Robert J Gropler; Thomas A Holly; John J Mahmarian; Mi-Ae Park; Donna M Polk; Raymond Russell; Piotr J Slomka; Randall C Thompson; R Glenn Wells Journal: J Nucl Cardiol Date: 2018-10 Impact factor: 5.952
Authors: Habib A Dakik; Wayne S Hwang; Aman Jafar; Kay Kimball; Mario S Verani; John J Mahmarian Journal: J Nucl Cardiol Date: 2005 Jan-Feb Impact factor: 5.952
Authors: R Hachamovitch; D S Berman; H Kiat; C N Bairey; I Cohen; A Cabico; J Friedman; G Germano; K F Van Train; G A Diamond Journal: J Am Coll Cardiol Date: 1996-07 Impact factor: 24.094
Authors: Ryo Nakazato; Daniel S Berman; Heidi Gransar; Mark Hyun; Romalisa Miranda-Peats; Faith C Kite; Sean W Hayes; Louise E J Thomson; John D Friedman; Alan Rozanski; Piotr J Slomka Journal: J Nucl Cardiol Date: 2012-10-12 Impact factor: 5.952
Authors: W Lane Duvall; Piotr J Slomka; Jim R Gerlach; Joseph M Sweeny; Usman Baber; Lori B Croft; Krista A Guma; Titus George; Milena J Henzlova Journal: J Nucl Cardiol Date: 2013-06-05 Impact factor: 5.952